NeurAxis (NRXS) Competitors $2.50 -0.12 (-4.58%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$2.52 +0.02 (+0.80%) As of 08/1/2025 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXS vs. ZYXI, NSPR, APYX, MDAI, ICCM, CTSO, SPAI, SURG, EDAP, and RBOTShould you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Zynex (ZYXI), InspireMD (NSPR), Apyx Medical (APYX), Spectral AI (MDAI), IceCure Medical (ICCM), Cytosorbents (CTSO), Safe Pro Group (SPAI), SurgePays (SURG), Edap Tms (EDAP), and Vicarious Surgical (RBOT). These companies are all part of the "medical equipment" industry. NeurAxis vs. Its Competitors Zynex InspireMD Apyx Medical Spectral AI IceCure Medical Cytosorbents Safe Pro Group SurgePays Edap Tms Vicarious Surgical NeurAxis (NASDAQ:NRXS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability. Do insiders & institutionals have more ownership in NRXS or ZYXI? 11.8% of NeurAxis shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 26.4% of NeurAxis shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts rate NRXS or ZYXI? NeurAxis currently has a consensus price target of $7.00, indicating a potential upside of 180.00%. Zynex has a consensus price target of $4.90, indicating a potential upside of 288.89%. Given Zynex's higher probable upside, analysts clearly believe Zynex is more favorable than NeurAxis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeurAxis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has preferable earnings & valuation, NRXS or ZYXI? Zynex has higher revenue and earnings than NeurAxis. Zynex is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeurAxis$2.93M6.15-$14.63M-$1.19-2.10Zynex$192.35M0.20$2.99M-$0.24-5.25 Does the media favor NRXS or ZYXI? In the previous week, Zynex had 11 more articles in the media than NeurAxis. MarketBeat recorded 12 mentions for Zynex and 1 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.00 beat Zynex's score of -0.09 indicating that NeurAxis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeurAxis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zynex 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is NRXS or ZYXI more profitable? Zynex has a net margin of -19.79% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Zynex's return on equity.Company Net Margins Return on Equity Return on Assets NeurAxis-492.76% N/A -641.25% Zynex -19.79%-59.71%-15.57% Which has more risk & volatility, NRXS or ZYXI? NeurAxis has a beta of 3.09, indicating that its share price is 209% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. SummaryZynex beats NeurAxis on 10 of the 15 factors compared between the two stocks. Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXS vs. The Competition Export to ExcelMetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.04M$33.45M$5.48B$9.53BDividend YieldN/AN/A4.73%4.09%P/E Ratio-1.363.0528.8623.83Price / Sales6.15198.51371.4466.13Price / CashN/A41.3635.4557.96Price / Book-9.261.788.265.54Net Income-$14.63M-$2.66M$3.25B$259.28M7 Day Performance-9.75%-5.68%-3.73%-4.67%1 Month Performance3.73%4.26%4.28%4.38%1 Year Performance-21.38%165.11%25.85%17.90% NeurAxis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXSNeurAxis2.6868 of 5 stars$2.50-4.6%$7.00+180.0%-22.4%$18.04M$2.93M-1.3619Upcoming EarningsZYXIZynex2.6065 of 5 stars$2.48-3.1%$5.50+121.8%-84.9%$74.99M$172.40M-10.33770News CoverageAnalyst UpgradeGap DownNSPRInspireMD3.6437 of 5 stars$2.45+0.2%$4.50+84.0%-7.6%$74.93M$7.03M-3.2650News CoverageAPYXApyx Medical1.1185 of 5 stars$1.96-19.0%N/A+32.6%$74.08M$47.29M-3.56270News CoverageUpcoming EarningsHigh Trading VolumeMDAISpectral AI2.2838 of 5 stars$2.52-8.4%$4.75+88.5%+43.9%$63.81M$29.58M-4.6783News CoverageICCMIceCure Medical2.0478 of 5 stars$1.04+1.0%$2.50+140.4%+52.3%$61.05M$3.29M-3.7160High Trading VolumeCTSOCytosorbents1.1907 of 5 stars$0.91-3.4%$5.50+504.4%-24.4%$56.98M$35.60M-3.25220News CoverageUpcoming EarningsGap UpSPAISafe Pro Group0.7919 of 5 stars$3.71-4.5%$8.00+115.9%N/A$56.21M$2.17M-4.5711Positive NewsSURGSurgePays3.2395 of 5 stars$2.71-4.2%$9.00+232.1%-0.7%$55.31M$60.88M-0.9740Positive NewsEDAPEdap Tms2.8161 of 5 stars$1.46-4.3%$8.50+482.2%-73.1%$54.59M$69.18M-2.35230Positive NewsRBOTVicarious Surgical0.88 of 5 stars$9.17-5.9%$8.50-7.3%+36.2%$54.39MN/A-0.88210News CoverageGap Up Related Companies and Tools Related Companies Zynex Alternatives InspireMD Alternatives Apyx Medical Alternatives Spectral AI Alternatives IceCure Medical Alternatives Cytosorbents Alternatives Safe Pro Group Alternatives SurgePays Alternatives Edap Tms Alternatives Vicarious Surgical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXS Stock Alerts